30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q13 Revenue: DJO Global

$288MM, +5%

  • Bracing/Vascular $120.9MM, +8%
  • Recovery Sciences $767MM, -4%
  • International $70.4MM, +7%
  • Surgical Implant $20MM, +16%

(Bracing and Vascular includes products serving the diabetes market.)


  • Bracing/Vascular segment supported by new products (DonJoy and Exos marking double-digit growth), improved sales execution
  • Recovery Sciences continues to feel effect of Medicare decision on TENS device, slow capital equipment sales
  • Surgical Implant supported by strong sales across hip, knee, shoulder (latter +14%)
  • Overall, sales growth a product of unit sales increase (vs. pricing)
  • Launched the Empi Phoenix electrical stimulator for treatment of muscle atrophy before and after total knee replacement or anterior cruciate ligament repair